Company / Interest Expense
Avanos Medical, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$15.0M
FY2023
5-year range
$3.3M / $15.0M
FY2019-FY2023
Trend
+50.0%
vs FY2022
Sector context
#32 of 40
Health Care
What the data says
Avanos Medical, Inc.'s interest expense of $15M is lower than 80% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 8 years, ranging from $3M in FY2021 to $33M in FY2016.
Based on SEC 10-K filings.
$15M in FY2023 with a 5-year CAGR of -10.7%.
Increased from $3M to $15M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 40This company $15.0M Sector average $332.7M
▼
-95.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.7%, indicating a declining trend.
- In FY2023, interest expense increased 50.0% year-over-year.
- Ranks #32 out of 40 companies in the Health Care sector.
- Peak interest expense was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $15.0M | +50.0% |
| FY2022 | $10.0M | +203.0% |
| FY2021 | $3.3M | -78.8% |
| FY2020 | $15.6M | +4.0% |
| FY2019 | $15.0M | -43.2% |
| FY2018 | $26.4M | -16.5% |
| FY2017 | $31.6M | -3.4% |
| FY2016 | $32.7M | -1.2% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026